Cargando…
Comorbidity of inflammatory bowel disease with atypical hemolytic uremic syndrome in pediatric patients
Atypical hemolytic uremic syndrome (aHUS) is a form of thrombotic microangiopathy mediated by dysregulation of the alternative complement pathway. Complement-amplifying conditions such as respiratory and gastrointestinal infections, pregnancy, malignancy, and systemic autoimmune diseases such as sys...
Autores principales: | Shin, H. Stella, Nester, Carla M., Dixon, Bradley P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595396/ https://www.ncbi.nlm.nih.gov/pubmed/31312592 http://dx.doi.org/10.5414/CNCS109511 |
Ejemplares similares
-
Successful use of eculizumab to treat atypical hemolytic uremic syndrome in patients with inflammatory bowel disease
por: Hanna, Ramy M., et al.
Publicado: (2019) -
Pediatric Atypical Hemolytic Uremic Syndrome Advances
por: Raina, Rupesh, et al.
Publicado: (2021) -
How atypical can Atypical Hemolytic Uremic Syndrome be?
por: Sajan, Thomas, et al.
Publicado: (2014) -
Atypical hemolytic uremic syndrome
por: Loirat, Chantal, et al.
Publicado: (2011) -
Atypical Hemolytic Uremic Syndrome
por: Kavanagh, David, et al.
Publicado: (2013)